Clinical Trials Logo

Filter by:
NCT ID: NCT03501056 Withdrawn - Clinical trials for Advanced Lung Cancer

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Lung Cancer

Start date: March 27, 2018
Phase: Phase 2
Study type: Interventional

This is a phase II Randomized comparison clinical trial of activated CIK armed with anti-CD3-MUC1 bispecific antibody for advanced lung cancer. And the aim of this research is to study the clinical efficacy and safety of activated CIK armed with anti-CD3-MUC1 bispecific antibody for lung cancer.

NCT ID: NCT03497338 Withdrawn - Hemorrhage Clinical Trials

New Anticoagulation Strategies of VV-ECMO

Start date: April 1, 2018
Phase:
Study type: Observational [Patient Registry]

Effective and normative anticoagulation is one of the most important components of Extracorporeal membrane oxygenation (ECMO) management. Excessive anticoagulation may lead to hemorrhage, which is the most common and serious complication. Currently, the most common factors for monitoring anticoagulation of ECMO are the activated clotting time (ACT) and activated partial thromboplastin time (APTT). However, there is a lack of a unified understanding of the related monitoring measures, monitoring targets, and bleeding risk assessments, which have been chosen mainly because of experiences reported by various ECMO centers or the results of retrospective studies.Therefore, anticoagulation strategies need to be improved. Our research have found ECMO anticoagulation management should be transformed from monitoring only the APTT/activated clotting time (ACT) to considering the entire coagulation process. To maintain thrombosis ability and PLT function within normal ranges may help reduce hemorrhage rates and improve prognoses. This randomized controlled study aim to develop the safety and efficacy new anticoagulation strategies of VV-ECMO.

NCT ID: NCT03492268 Withdrawn - Multiple Myeloma Clinical Trials

Safety and Efficacy Evaluation of BCMA-CART for Treating Multiple Myeloma

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

This trial aims to evaluate the safety and efficacy of BCMA-CART in treating patients with relapsed or refractory multiple myeloma.

NCT ID: NCT03488940 Withdrawn - Sepsis Clinical Trials

Effect of Different Feeding Method on Gastrointestinal Function of Septic Patients (DFM-GF Trial)

DFM-GF
Start date: January 1, 2019
Phase: N/A
Study type: Interventional

The intestine is the most vulnerable target organ in septic patients and is the first to be damaged organ in multiple organ dysfunction syndrome(MODS). Therefore, improving intestinal motility and mucosal barrier function is critical to the treatment of sepsis. Many studies have shown that, early enteral nutrition(EN) in patients with sepsis helps prevent and treat intestinal dysfunction, reducing ICU mortality and length of stay in ICU. However, there is little research on feeding methods. In this study we will compare the outcomes of different feeding methods: continuously-pumped in 24 hours, continuously-pumped in 16 hours and intermittently-pumped through the stomach tube. The aim of this study is to investigate the effects of different feeding methods on intestinal function in septic patients.

NCT ID: NCT03484962 Withdrawn - Clinical trials for Advanced Liver Cancer

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer

Start date: March 25, 2018
Phase: Phase 2
Study type: Interventional

This is a phase II Randomized comparison clinical trial of activated CIK armed with anti-CD3-MUC1 bispecific antibody for advanced liver cancer. And the aim of this research is to study the clinical efficacy and safety of activated CIK armed with anti-CD3-MUC1 bispecific antibody for liver cancer.

NCT ID: NCT03475537 Withdrawn - Clinical trials for Transcranial Direct Current Stimulation

tDCS in Patients With Disorders of Consciousness

Start date: April 15, 2018
Phase: N/A
Study type: Interventional

test

NCT ID: NCT03421041 Withdrawn - Infertility, Female Clinical Trials

Study of Value of Dexamethasone Used in Ovulation Induction

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

This study intends to solve the following problems: whether use dexamethasone can obviously decrease transplant cancelling probability in fresh embryo transplant cycle or not, reduce time and frequency going to hospital repeatedly for patients need frozen embryo transplant or not, and reduce the economic burden for patients or not; By comparing pregnancy rate of single transplant, hope to make clear in IVF-ET treatment for patients progesterone increases to a certain level whether it is a good choice to transfer fresh embryo after dexamethasone treatment, or frozen embryo transplant is better.

NCT ID: NCT03413930 Withdrawn - Rectal Cancer Clinical Trials

Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer

Start date: June 2019
Phase: N/A
Study type: Interventional

This study is designed to evaluate the short-term and long-term results after transanal total mesorectal excision (TaTME) for the resection of mid and low rectal cancer compared with laparoscopic total mesorectal excision(LaTME).

NCT ID: NCT03409094 Withdrawn - Child Development Clinical Trials

Dongguan Eye Study of Schoolchildren and Adolescents(DESSA)

Start date: January 1, 2019
Phase:
Study type: Observational

This is a study to report the change of ocular biometry of schoolchildren and adolescents as well as its association with birth parameters in China.

NCT ID: NCT03401736 Withdrawn - Clinical trials for Mechanical Ventilation

The Diversity of Intestinal Microbiota in Patients With Different Sedative-hypnotics Undergoing Mechanical Ventilation

Start date: March 1, 2018
Phase: N/A
Study type: Interventional

Bidirectional communication between the CNS and the GI tract - the brain-gut axis - occurs both in health and disease.Patients with mechanical ventilation in ICU (ICU) often meet the necessary nutritional needs. These patients often appear varying degrees of intestinal flora imbalance, such as diarrhea, vomiting, abdominal distension and other complications, which exert negative effect on treatment and prolong hospitalization time.So far,whether the sedative drugs used for a long time in mechanically ventilated patients will affect the diversity of intestinal flora or not has not been reported.The effects of different sedative drugs on the intestinal flora diversity need further study.Therefore, this topic will used midazolam and dexmedetomidine to study the effect on the diversity of intestinal microbiota.Meanwhile,the research will provide a theoretical basis for rational use of mechanical ventilation and sedative drugs.